Dr. Raman Tuli

Participates in 2 items

Sessions in which Dr. Raman Tuli participates

Saturday 26 June, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

3:50 PM

Faricimab in Neovascular Age-Related Macular Degeneration: One-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials

3:51 PM - 3:59 PM | 8 minutes

Retina

Authors: Raman Tuli, 1.Carlos Quezada Ruiz, 2.David Silverman, 3.Vaibhavi Patel, 4.Karen Basu, 5.Hugh Lin. Author Disclosure Block: R. Tuli: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Hoffman Laroche Ltd. Any direct financial payments including receipt of honoraria; Description of relationship(s); Consultant. Funded grants or clinical trials; Name of for-profit or no...

Sunday 27 June, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

4:05 PM

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab(PDS) for Patients With Neovascular AMD

4:07 PM - 4:15 PM | 8 minutes

Retina

Authors: Raman Tuli, Peter A. Campochiaro, Natasha Singh, David Kardatzke, Steven Blotner, Shienal Patel, Giulio Barteselli. Disclosure Block: R. Tuli: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Hoffmann La Roche. Any direct financial payments including receipt of honoraria; Description of relationship(s); Consultant. Funded grants or clinical trials; Name of for-profit or...